Surgical treatment in ovarian cancer prevention in carriers of the BRCA1/BRCA2 mutation

被引：0
|
作者：
Synowiec, Agnieszka [1 ]
Wcislo, Gabriel [1 ]
Bodnar, Lubomir [1 ]
Szczylik, Cezary [1 ]
机构：
[1] Wojskowy Inst Med Warszawie, Klin Onkol, Warsaw, Poland
来源：
GINEKOLOGIA POLSKA | 2012年 / 83卷 / 01期
关键词：
BRCA1; BRCA2; ovarian cancer; prophylaxis bilateral salpingo-oophovectomy; REDUCING SALPINGO-OOPHORECTOMY; PROPHYLACTIC OOPHORECTOMY; BREAST-CANCER; HEREDITARY BREAST; FALLOPIAN-TUBE; RISK REDUCTION; BRCA1; WOMEN; SURGERY; STATEMENT;
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Ovarian cancer remains to be a real challenge in spite of considerable progress in many areas of modern medicine. The use of genetic testing for detecting mutations of the BRCA genes has been offering clinical scrutiny between mutated versions of the BRCA genes and higher risk of both breast and ovarian cancer A population survey is a method of choice to find out more efficient screening management in order to identify cancer patients who further will be treated effectively early. A review of literature on surgical PBSO (prophylactic bilateral salpingooophorectomy) in the BRCA genes mutations carriers with focus on preventive results against morbidity of ovarian cancer has been presented in the article.
引用
收藏
页码：51 / 56
页数：6
相关论文
共 50 条
  • [1] Hereditary breast and ovarian cancer:: primary and secondary prevention for BRCA1 and BRCA2 mutation carriers
    Llort, Gemma
    Blanco, Merce Peris e Ignacio
    MEDICINA CLINICA, 2007, 128 (12): : 468 - 476
  • [2] Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers
    Milne, Roger L.
    Antoniou, Antonis C.
    ENDOCRINE-RELATED CANCER, 2016, 23 (10) : T69 - T84
  • [3] Weight gain and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Kim, Shana
    Lubinski, Jan
    Huzarski, Tomasz
    Moller, Pal
    Armel, Susan
    Karlan, Beth
    Senter, Leigha
    Eisen, Andrea
    Foulkes, William
    Singer, Christian
    Tung, Nadine
    Bordeleau, Louise
    Neuhausen, Susan
    Olopade, Olufunmilayo
    Eng, Charis
    Weitzel, Jeffrey
    Fruscio, Robert
    Narod, Steven
    Kotsopoulos, Joanne
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 : S357 - S358
  • [4] Contraceptive use and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers
    Xia, Yue Yin
    Lubinski, Jan
    Rosen, Barry
    Moller, Pal
    Eisen, Andrea
    Ainsworth, Peter
    Senter, Leigha
    Neuhausen, Susan
    Singer, Christian
    Brooks, Jennifer
    Sun, Ping
    Narod, Steven
    Kotsopoulos, Joanne
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 : S50 - S51
  • [5] Nonsurgical Prevention Strategies in BRCA1 and BRCA2 Mutation Carriers
    Singer, Christian F.
    BREAST CARE, 2021, 16 (02) : 144 - 148
  • [6] Weight Gain and the Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation Carriers
    Kim, Shana J.
    Lubinski, Jan
    Huzarski, Tomasz
    Moller, Pal
    Armel, Susan
    Karlan, Beth Y.
    Senter, Leigha
    Eisen, Andrea
    Foulkes, William D.
    Singer, Christian F.
    Tung, Nadine
    Bordeleau, Louise
    Neuhausen, Susan L.
    Olopade, Olufunmilayo, I
    Eng, Charis
    Weitzel, Jeffrey N.
    Fruscio, Robert
    Narod, Steven A.
    Kotsopoulos, Joanne
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (11) : 2038 - 2043
  • [7] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Milne, Roger L.
    Osorio, Ana
    Ramon y Cajal, Teresa
    Baiget, Montserrat
    Lasa, Adriana
    Diaz-Rubio, Eduardo
    de la Hoya, Miguel
    Caldes, Trinidad
    Teule, Alex
    Lazaro, Conxi
    Blanco, Ignacio
    Balmana, Judith
    Sanchez-Olle, Gessami
    Vega, Ana
    Blanco, Ana
    Chirivella, Isabel
    Esteban Cardenosa, Eva
    Duran, Mercedes
    Velasco, Eladio
    Martinez de Duenas, Eduardo
    Tejada, Maria-Isabel
    Miramar, Maria-Dolores
    Calvo, Maria-Teresa
    Guillen-Ponce, Carmen
    Salazar, Raquel
    San Roman, Carlos
    Urioste, Miguel
    Benitez, Javier
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) : 221 - 232
  • [8] Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Ramus, Susan J.
    Antoniou, Antonis C.
    Kuchenbaecker, Karoline B.
    Soucy, Penny
    Beesley, Jonathan
    Chen, Xiaoqing
    McGuffog, Lesley
    Sinilnikova, Olga M.
    Healey, Sue
    Barrowdale, Daniel
    Lee, Andrew
    Thomassen, Mads
    HUMAN MUTATION, 2012, 33 (04) : 690 - 702
  • [9] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Roger L. Milne
    Ana Osorio
    Teresa Ramón y Cajal
    Montserrat Baiget
    Adriana Lasa
    Eduardo Diaz-Rubio
    Miguel de la Hoya
    Trinidad Caldés
    Alex Teulé
    Conxi Lázaro
    Ignacio Blanco
    Judith Balmaña
    Gessamí Sánchez-Ollé
    Ana Vega
    Ana Blanco
    Isabel Chirivella
    Eva Esteban Cardeñosa
    Mercedes Durán
    Eladio Velasco
    Eduardo Martínez de Dueñas
    María-Isabel Tejada
    María-Dolores Miramar
    María-Teresa Calvo
    Carmen Guillén-Ponce
    Raquel Salazar
    Carlos San Román
    Miguel Urioste
    Javier Benítez
    Breast Cancer Research and Treatment, 2010, 119 : 221 - 232
  • [10] Breast cancer prevention for BRCA1 and BRCA2 mutation carriers: is there a role for tamoxifen?
    Phillips, Kelly-Anne
    Lindeman, Geoffrey J.
    FUTURE ONCOLOGY, 2014, 10 (04) : 499 - 502
12345